Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • BFSI
      • Capital Goods
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Press Release»Sarvodaya Hospital Performs Youngest Cochlear Implant On 5-Month-Old Baby In India
    Press Release

    Sarvodaya Hospital Performs Youngest Cochlear Implant On 5-Month-Old Baby In India

    WebDeskBy WebDeskNovember 21, 2024No Comments5 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi [India], November 21:  Strengthening their commitment to serving people through quality medical services and empathetic care for over three decades, Sarvodaya Hospital, Faridabad, achieved another medical breakthrough by treating a 5-months-old baby for congenital hearing impairment, making him the youngest in India to undergo cochlear implant surgery. The baby was suffering from congenital hearing impairment. The team of doctors led by Dr. Ravi Bhatia, Director- of ENT and Cochlear Implants, performed a cochlear implant, which involves the placement of a small electronic device into the ear of a patient suffering from hearing loss. This case also highlights the need and importance of screening and identifying conditions in young lives early on for optimal treatment and improved quality of life.

    4-6 out of every 1000 children born in India are detected to have congenital hearing loss, a condition in which a child is born without the ability to hear. This type of hearing loss occurs either due to abnormal development of the auditory system during fetal development or as a result of genetic inheritance from the parents. Many newborns are not screened for hearing loss at birth. Hence, the actual incidence is expected to be much higher in the community.

    The baby was brought to Sarvodaya Hospital’s Centre of ENT and Cochlear Implant at the age of 4.5 months after his grandparents noticed his lack of response to basic every day sounds like claps and cooker whistles. The baby’s father was also suffering from congenital hearing impairment, which led to a rise in the family’s concern about the baby. Prior to this, the baby was screened at a local clinic, and the diagnosis revealed a profound hearing loss in both his ears. A detailed audiological evaluation was conducted once he was brought to Sarvodaya Hospital comprising advanced diagnostic tools, including Tympanometry (test to assess the functioning of the middle ear), Oto-Acoustic Emissions (measures cell function in the inner ear), Auditory Brainstem Response (used to assess the function of Auditory nerve and Auditory pathway), and imaging studies like CT and MRI, which confirmed the severity of his condition. Post this, the team of doctors decided to conduct a cochlear implant surgery, and now, at 10 months old, the baby is living a healthy, normal life following the successful procedure.

    Hospital

    Commenting on the case, Dr Ravi Bhatia, Director- ENT and Cochlear Implants, Sarvodaya Hospital, Faridabad, said, “At Sarvodaya Hospital, we have successfully performed over 300 cochlear implants, transforming the hearing abilities and quality of life for countless patients. This case study exemplifies our commitment to providing advanced cochlear implant surgeries through compassionate care, cutting–edge technology, accessibility, affordability, patient safety, and quality. While cochlear implants can be done at any age, the timing of hearing loss onset plays a critical role in the success of the procedure. Early detection and intervention are especially vital for children with severe to profound hearing loss, as they can lead to immediate and positive outcomes. Cochlear implants can be life-changing, enabling children to interact with the auditory world, develop normal speech and language skills, and keep pace with their peers who have normal hearing. The cost of treatment ranges around 8-10 lakhs, as the hospital is empanelled in Government schemes and NGOs; for underprivileged children, the treatment is done at free of cost ’’

    Mr. Raja Suman, Chief Audiologist, Centre of ENT and Cochlear Implant, Sarvodaya Hospital, Faridabad, further added, “The child is undergoing continuous monitoring to ensure optimal progress. Our team of professionals, including audiologists, auditory-verbal therapists, and speech-language pathologists, closely tracks the child’s auditory development, speech, and language milestones. This comprehensive approach aimed to provide tailored support and guidance throughout the rehabilitation process, enabling the child to hear successfully.”

    Cochlear implants function by bypassing damaged parts of the ear to directly stimulate the auditory nerve. The device consists of two components: an internal device, surgically implanted inside the ear, and an external device, which includes a speech processor, transmitting coil, and microphone. The external component captures sound and converts it into digital signals, which are sent to the internal device. The internal device then stimulates the auditory nerve, allowing sound signals to reach the brain, enabling the person to hear.

    About Sarvodaya Healthcare:

    Sarvodaya Healthcare is a pioneering healthcare group that has been serving the community for over the last 32 years. With a commitment to affordable and top-class medical facilities and compassionate care, the journey began three decades ago with a mission: Sarve Santu Niramaya, which translates to “Good health for all”, regardless of background or ailment. The vision was to provide accessible and high-quality medical services.

    Over the years, the trust and support of the patients and their families have propelled Sarvodaya forward. From a modest 5-bedded clinic, the hospital has grown into an 800-bedded healthcare group encompassing tertiary and secondary care hospitals, nursing and paramedic institutes, health clinics, diagnostic and imaging centres, and dialysis facilities across Faridabad, Greater Noida, Delhi, and other cities in the National Capital Region.

    Sarvodaya Healthcare harnesses cutting-edge technology alongside a team of skilled specialists to offer advanced treatments across various super specialities. These include Cancer Care and Bone Marrow Transplants, Nuclear Medicine and Theranostics, Radiotherapy, Orthopedics and Robotic Joint Replacement, Neurosciences, Pediatric to Adult Cardiology and Cardiac Surgeries, Dialysis and Kidney Transplants, Minimal Access Surgery, Gastroenterology and GI Surgeries, Urology and LASER Urological Surgeries, ENT and Cochlear Implants, Diabetes and Endocrinology, Plastic and Reconstructive Surgery, Rheumatology, Pulmonology, and more.

    If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    PR press-release
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    WebDesk
    • Website

    Related Posts

    Crossword launches Japanese‘Manga Mania’ collection across its 130+ stores in India

    September 10, 2026

    Le Méridien, New Delhi to host 23rd Annual Chef Awards 2026

    September 10, 2026

    ABS India appoints Puneet Saxena as CEO to scale up its enterprise and mission-critical technology business

    September 9, 2026

    Comments are closed.

    Recent Post
    • Olympian Pranati Nayak from Odisha, AM/NS India Gymnastics High-Performance Centre to represent India at Asian Games 2026
    • Singer Shivaay Makes Singing Debut with Soulful Single ‘Hanju’, Lyrics by Kumaarji, Video by Ramji Gulati, Marks Birthday with Annual Singing Mela
    • Medicinal & Aromatic Plants Company Focused on Lemongrass Cultivation, Processing and Essential Oils Opens IPO on September 15, 2026
    • Vishal Fabrics Receives Credit Ratings from India Ratings for Bank Facilities
    • Vama Wovenfab Limited Announces Rs. 47.07–Rs. 49.54 Crore SME Initial Public Offering; Issue Opens on Tuesday, 15 September 2026
    • All Praises for Shanti and Amani: The No. 1 Bestseller Kids and Parents Can’t Stop Talking About is out with the Sequel
    • WION announces WION World Conferences — A Global Platform for the Power of Ideas
    • Aadrika Associates Private Limited Strengthens Its Focus on Indore’s Growing Commercial Real Estate Market

    Type above and press Enter to search. Press Esc to cancel.